Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Glioblastoma 11Glioma 7Neuroblastoma 6Pheochromocytoma 3Paraganglioma 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Wilms Tumor 1Thyroid cancer, medullary 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Neoplasms 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Medulloblastoma 1Insulinoma 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Dysbiosis 1Disease Progression 1Disease 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

fluorodopa F 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Thyroid cancer, medullary × CNS × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡